Vaccine effectiveness and duration of protection against symptomatic infections and severe Covid-19 outcomes in adults aged 50 years and over, France, January to mid-December 2021

BACKGROUND: SARS-CoV-2 continues to spread despite fast vaccine rollout, which could be attributed to waning immunity or to a reduced protection against some variants. A thorough characterization of vaccine protection and its duration in time is needed to inform vaccination policies and enhance publ...

Descripción completa

Detalles Bibliográficos
Autores principales: Suarez Castillo, Milena, Khaoua, Hamid, Courtejoie, Noémie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135646/
https://www.ncbi.nlm.nih.gov/pubmed/35662871
http://dx.doi.org/10.1016/j.gloepi.2022.100076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135646/
https://www.ncbi.nlm.nih.gov/pubmed/35662871
http://dx.doi.org/10.1016/j.gloepi.2022.100076

Ejemplares similares